Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives $20.13 Average PT from Analysts
Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) have been assigned an average recommendation of “Buy” from the eleven brokerages that are presently covering the firm, Marketbeat Ratings reports. Ten investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average […]
Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) have been assigned an average recommendation of “Buy” from the eleven brokerages that are presently covering the firm, Marketbeat Ratings reports. Ten investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average […]
